Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis

Although there have been significant advances in the treatment of visceral leishmaniasis (VL) and several novel compounds are currently in pre-clinical and clinical development for this manifestation of leishmaniasis, there have been limited advances in drug research and development (R & D) for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Parasitol Drugs Drug Resist
Autores principales: Caridha, Diana, Vesely, Brian, van Bocxlaer, Katrien, Arana, Byron, Mowbray, Charles E., Rafati, Sima, Uliana, Silvia, Reguera, Rosa, Kreishman-Deitrick, Mara, Sciotti, Richard, Buffet, Pierre, Croft, Simon L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2019
Materias:
Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904839/
https://ncbi.nlm.nih.gov/pubmed/31320296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.06.003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares